User profiles for Diego Rodrigues Falci
Diego Rodrigues FalciHCPA/UFRGS Verified email at hcpa.edu.br Cited by 4096 |
Effect of sotrovimab on hospitalization or death among high-risk patients with mild to moderate COVID-19: a randomized clinical trial
…, E Juarez, MC Casal, J Moya, DR Falci… - Jama, 2022 - jamanetwork.com
Importance Older patients and those with comorbidities who are infected with SARS-CoV-2
may be at increased risk of hospitalization and death. Sotrovimab is a neutralizing antibody …
may be at increased risk of hospitalization and death. Sotrovimab is a neutralizing antibody …
Isolation of NDM-producing Providencia rettgeri in Brazil
…, LN Timm, RCF Da Silva, DR Falci… - Journal of …, 2013 - academic.oup.com
Sir, New Delhi metallo-b-lactamase (NDM) was first identified in 2009 in a Klebsiella pneumoniae
isolated from a patient in a Swedish hospital who had been previously hospitalized in …
isolated from a patient in a Swedish hospital who had been previously hospitalized in …
Combination therapy with polymyxin B for carbapenemase-producing Klebsiella pneumoniae bloodstream infection
GS Medeiros, MH Rigatto, DR Falci… - International journal of …, 2019 - Elsevier
Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) bloodstream
infections (BSIs) are related to high mortality rates, and combination therapy has been …
infections (BSIs) are related to high mortality rates, and combination therapy has been …
Effect of the neutralizing SARS-CoV-2 antibody sotrovimab in preventing progression of COVID-19: a randomized clinical trial
…, E Juarez, MC Casal, J Moya, DR Falci… - medRxiv, 2021 - medrxiv.org
Importance Older patients and those with underlying comorbidities infected with SARS-CoV-2
may be at increased risk of hospitalization and death from COVID-19. Sotrovimab is a …
may be at increased risk of hospitalization and death from COVID-19. Sotrovimab is a …
A contemporary investigation of burden and natural history of aspergillosis in people living with HIV/AIDS
VSS Truda, DR Falci, FMV Porfírio, DWCL de Santos… - Mycoses, 2023 - Wiley Online Library
Background Untreated HIV infection can lead to profound immunosuppression and increase
susceptibility of people living with HIV/AIDS (PLHA) to aspergillosis. Objectives Reporting …
susceptibility of people living with HIV/AIDS (PLHA) to aspergillosis. Objectives Reporting …
[HTML][HTML] Epidemiology and risk factors for mortality among methicillin-resistant Staphylococcus aureus bacteremic patients in Southern Brazil
This study aimed to evaluate the epidemiology and 30-day mortality of adult patients with
methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. We retrospectively reviewed …
methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. We retrospectively reviewed …
Early Covid-19 Treatment With SARS-CoV-2 Neutralizing Antibody Sotrovimab (preprint)
…, E Juarez, MC Casal, J Moya, DR Falci… - 2021 - pesquisa.bvsalud.org
Background: Coronavirus disease 2019 (Covid-19) disproportionately results in hospitalization
and death in older patients and those with underlying comorbidities. Sotrovimab is a pan-…
and death in older patients and those with underlying comorbidities. Sotrovimab is a pan-…
Continuous infusion of amphotericin B deoxycholate in the treatment of cryptococcal meningoencephalitis: analysis of safety and fungicidal activity
DR Falci, LW Lunardi, CG Ramos… - Clinical Infectious …, 2010 - academic.oup.com
We measured fungicidal activity of continuous infusion of amphotericin B deoxycholate plus
5″flucytosine using quantitative cultures of cerebrospinal fluid (CSF) obtained from lumbar …
5″flucytosine using quantitative cultures of cerebrospinal fluid (CSF) obtained from lumbar …
Characteristics, mortality, associated variables with death, and therapeutic response among HIV-positive, solid organ transplant (SOT), and non-HIV-positive/non …
…, MMC Magri, DR Falci… - Medical …, 2023 - academic.oup.com
Cryptococcosis is traditionally associated with immunocompromised patients but is
increasingly being identified in those without the human immunodeficiency virus (HIV) or other …
increasingly being identified in those without the human immunodeficiency virus (HIV) or other …
Effectiveness, Tolerability, and Safety of Different Amphotericin B Formulations in Invasive Fungal Infections: A Multicenter, Retrospective, Observational Study
…, MMC Magri, JE Vidal, FAMC Carlesse, DR Falci… - Clinical Therapeutics, 2024 - Elsevier
Purpose Data on the real-life use of amphotericin B lipid complex (ABLC) compared with
other available formulations are limited. This study aimed to evaluate the effectiveness, …
other available formulations are limited. This study aimed to evaluate the effectiveness, …